BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - IPO, Updates
Cerulean Pharma Inc. (CERU) Announces Closing Of Initial Public Offering 4/15/2014  More...
Cerulean Pharma Inc. (CERU) Announces Pricing Of Initial Public Offering 4/10/2014  More...
Emeryville's Adamas Pharmaceuticals (ADMS) IPO Prices At $16, Low End Of Range 4/10/2014  More...
Applied Genetic Technologies Corporation Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/4/2014  More...
Bay Area's Corium International, Inc. Schedules In A $60 Million IPO 4/3/2014  More...
Versartis, Inc. (VSAR) Announces Closing Of Its Initial Public Offering And Full Exercise Of Over-Allottment Option 3/27/2014  More...
MediWound (MDWD) Announces Closing Of Initial Public Offering 3/26/2014  More...
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014  More...
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014  More...
MediWound (MDWD) Prices IPO At $14 Share 3/20/2014  More...
Seattle Biotech Alder Biopharmaceuticals Inc. Files For A $115 Million IPO 3/19/2014  More...
Achaogen (AKAO) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Over-Allotment Option To Purchase Additional Shares 3/18/2014  More...
Galmed Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/18/2014  More...
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014  More...
New York-Based Dipexium Pharmaceuticals (DPRX) Prices Upsized IPO At $12, Raises $33 Million 3/13/2014  More...
Recro Pharma (REPH) Announces Closing Of Initial Public Offering 3/13/2014  More...
Galmed Pharmaceuticals Debuts Upsized IPO, Raises $38 Million 3/13/2014  More...
Aquinox Pharmaceuticals (AQXP) Announces Closing Of Initial Public Offering 3/12/2014  More...
NeuroVive Pharmaceutical AB: Neurovive Starts Collaboration To Evaluate IPO Of Subsidiary In Taiwan 3/10/2014  More...
Egalet IPO Underwriters Exercise Over-Allotment Option 3/10/2014  More...
Small Biotech Recro Pharma (REPH) Secures A $30 Million IPO Feat 3/7/2014  More...
Durham's SCYNEXIS, Inc. Files For $55 Million IPO 3/3/2014  More...
Revamped Radius Looks To Cash In With $86 Million IPO 2/27/2014  More...
Antibacterial Biotech Achaogen Sets Terms For $65 Million IPO 2/25/2014  More...
Beijing Genomics Institute (BGI) Rumored To Stage $400 Million IPO In Late 2014 2/24/2014  More...
Flexion Therapeutics (FLXN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2014  More...
Concert Pharmaceuticals, Inc. (CNCE) Announces Closing Of Initial Public Offering 2/19/2014  More...
NephroGenex (NRX) Announces Closing Of Initial Public Offering 2/17/2014  More...
Concert Pharmaceuticals, Inc. (CNCE) Heads To Nasdaq, Prices At High End Of The Range 2/13/2014  More...
Eagle Pharmaceuticals (EGRX) Eyes $50 Million In IPO 2/12/2014  More...
ReVance Therapeutics, Inc. (RVNC) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Over-Allotment Option 2/12/2014  More...
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014  More...
NephroGenex (NRX) Prices IPO At Low End Of Range, Will Reap About $37.2 Million 2/11/2014  More...
Eleven Biotherapeutics (EBIO) Closes Initial Public Offering 2/11/2014  More...
uniQure Announces Closing of Initial Public Offering 2/10/2014  More...
Genocea Biosciences Announces Closing Of Initial Public Offering 2/10/2014  More...
Luye Pharma Group Ltd. To Conduct $750 Million Hong Kong IPO 2/10/2014  More...
Argos Therapeutics, Inc. (ARGS) Prices Lower Than Expected IPO, Raises $45 Million 2/7/2014  More...
Eleven Biotherapeutics (EBIO) Prices Downsized IPO, Grabs $50 Million 2/6/2014  More...
Ultragenyx Pharmaceuticals Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 2/6/2014  More...
Egalet Announces Pricing Of Initial Public Offering 2/6/2014  More...
Circassia Limited Seeks $285 Million In One Of Europe's Biggest Biotech IPOs 2/6/2014  More...
Bay Area's ReVance Therapeutics, Inc. (RVNC) Prices IPO At Top Of Range, Raises $96 Million 2/6/2014  More...
Auspex Pharmaceuticals Announces Pricing Of Initial Public Offering 2/5/2014  More...
uniQure Announces Pricing Of Initial Public Offering 2/5/2014  More...
Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO 2/4/2014  More...
Cara Therapeutics, Inc. (CARA) Scrounges Up $55 Million In Downsized IPO 1/31/2014  More...
CytRx Corporation (CYTR) Announces Proposed Public Offering of Common Stock 1/31/2014  More...
Trevena, Inc. (TRVN) Gives IPO Another Whirl After Postponing Two Months Ago 1/31/2014  More...
Dicerna Pharmaceuticals (DRNA) Prices Upsized IPO At $15 Per Share 1/30/2014  More...
Potential $95 Million Ultragenyx Pharmaceuticals IPO Leads Biotech Class Of '14 1/30/2014  More...
Celladon Corporation Announces Pricing Of Initial Public Offering 1/30/2014  More...
Tesaro, Inc. (TSRO) Announces Proposed Public Offering Of Common Stock 1/29/2014  More...
Zhejiang Wolwo Bio-Pharma Gains 94% Post-IPO 1/27/2014  More...
Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO 1/27/2014  More...
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014  More...
Jiangsu ASK Pharma Postpones ChiNext IPO 1/13/2014  More...
GlycoMimetics, Inc. (GLYC) Finally Prices Upraised IPO At $8 Per Share 1/10/2014  More...
ReVance Therapeutics, Inc. Files $86.25 Million IPO 1/3/2014  More...
Seattle Biotech Acucela Inc. Seeks $125 Million IPO in Japan to Develop Eye Drugs 12/18/2013  More...
Consun Pharma Schedules Hong Kong IPO 12/13/2013  More...
Kindred Bio (KIN) Prices $52.5 Million IPO For Biopharma Pet R&D 12/12/2013  More...
TetraLogic Pharmaceuticals (TLOG) Slashes Proposed IPO Price To $7, Deal Size Is Now $46 Million 12/12/2013  More...
Karyopharm Therapeutics (KPTI) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares In Its Initial Public Offering 12/11/2013  More...
Xencor Announces Closing Of Initial Public Offering 12/6/2013  More...
Innate Immunotherapeutics Launches IPO To Raise Up To A$12 Million 11/27/2013  More...
San Diego’s Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off 11/22/2013  More...
Relypsa, Inc. (RLYP) Announces Closing Of Initial Public Offering 11/21/2013  More...
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013  More...
Relypsa, Inc. (RLYP) Slashes IPO Target Price By Nearly A Third 11/15/2013  More...
GlycoMimetics, Inc. Postpones $60 Million IPO 11/8/2013  More...
Karyopharm Therapeutics (KPTI) Raises $109 Million in Upsized IPO, Begins Trading Today 11/6/2013  More...
Cardiovascular Biotech Celladon Corporation Sets Terms for $75 Million IPO 11/4/2013  More...
Biotech GlobeImmune, Inc. Withdraws $60 Million IPO 11/1/2013  More...
Aerie Pharmaceuticals, Inc. (AERI) Reels in $67 Million in IPO 10/25/2013  More...
ADMA Biologics, Inc. Announces Closing of Initial Public Offering 10/23/2013  More...
Veeva Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 10/21/2013  More...
Late-Stage Biotech Relypsa, Inc. Seeks $138 Million in Upsized IPO 10/18/2013  More...
ADMA Biologics, Inc. Announces Pricing of Initial Public Offering 10/17/2013  More...
MacroGenics, Inc. (MGNX) Hikes Size of Planned IPO to $92 Million 10/10/2013  More...
GlycoMimetics, Inc. Seeks Up to $86 Million in IPO 10/8/2013  More...
Enzymotec Announces Pricing of Its Initial Public Offering 9/27/2013  More...
BIND Therapeutics Announces Closing of Initial Public Offering 9/26/2013  More...
Ophthotech Corporation (OPHT) Reels in $167 Million in IPO 9/25/2013  More...
Foundation Medicine, Inc. (FMI) Lands $106 Million in Upsized IPO 9/25/2013  More...
BIND Therapeutics Scrounges Up $70.5 Million in IPO 9/20/2013  More...
With Support From Celgene (CELG) and Other Investors, Acceleron Pharma Raises $93 Million in IPO 9/19/2013  More...
Sophiris Bio Inc. (SHS.TO) Closes $65 Million Public Offering 8/23/2013  More...
Regado Biosciences, Inc. (RGDO) Finally Goes Public, Raised $43 Million 8/22/2013  More...
Regado Biosciences Downsizes IPO, Seeks $42 Million 8/20/2013  More...
A Quick Glance at the Biotech IPO Boom 8/14/2013  More...
BrainStorm Cell Therapeutics Inc. Announces Pricing of Underwritten Public Offering 8/13/2013  More...
Intrexon Corporation Prices Initial Public Offering 8/8/2013  More...
IntelliPharmaCeutics Closes Public Offering for US$3.1 Million 8/1/2013  More...
Onconova Therapeutics Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option 7/31/2013  More...
Agios Pharmaceuticals Closes Initial Public Offering 7/30/2013  More...
IntelliPharmaCeutics Announces Pricing of Public Offering of Common Shares and Warrants 7/26/2013  More...
Cellular Dynamics International Raises $46 Million in IPO 7/25/2013  More...
Conatus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering 7/25/2013  More...
Onconova Therapeutics Inc. Announces Pricing of Initial Public Offering 7/25/2013  More...
OncoMed Pharmaceuticals, Inc. Announces Closing of Initial Public Offering 7/24/2013  More...
OncoMed Pharmaceuticals, Inc. IPO Rakes in $72 Million 7/18/2013  More...
Heat Biologics Hikes IPO to $33 Million From $24 Million 7/11/2013  More...
Biotech Conatus Pharmaceuticals Inc. Sets Terms for $55 Million IPO 7/10/2013  More...
OncoMed Pharmaceuticals, Inc. Prices IPO at $14-$16 Per Share, Targets $74 Million 7/9/2013  More...
Prosensa Holding N.V. Announces Closing of Initial Public Offering 7/8/2013  More...
ProSensa B.V. Raises $78 Million in IPO 6/28/2013  More...
Esperion Therapeutics, Inc. Prices Upsized $70 Million IPO for Statin Alternative Work 6/27/2013  More...
PTC Therapeutics, Inc. IPO Raises $125 Million Despite Checkered Past 6/20/2013  More...
bluebird bio Prices Upsized IPO Above the Range at $17 6/19/2013  More...
Aratana Therapeutics Postpones $51 Million IPO 6/19/2013  More...
Kadimastem Has Successfully Completed an IPO and Raised $5.5 Million USD 6/10/2013  More...
CSRC Terminates IPO Applications of 15 China Life Science Companies 6/6/2013  More...
Kamada Ltd. (KMDA.TA) Announces Closing of Initial Public Offering and Over-Allotment Option Exercise 6/5/2013  More...
Kamada Ltd. (KMDA.TA) Announces Pricing of Initial Public Offering 6/5/2013  More...
Evoke Pharma, Inc. Files $24 Million IPO 5/31/2013  More...
Epizyme (EPZM) Prices IPO at $15 Per Share, Begins Trading Today 5/31/2013  More...
Portola Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Over-Allotment Option Exercise 5/30/2013  More...
Alcobra Raises $25 Million on NASDAQ 5/29/2013  More...
Ironwood Pharmaceuticals Prices $136.5 Million Stock Offering 5/22/2013  More...
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug 5/21/2013  More...
Ambit Biosciences Cuts IPO Price 5/16/2013  More...
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire 5/10/2013  More...
Quintiles, Inc. (QTRN) Celebrates IPO on the New York Stock Exchange 5/10/2013  More...
Receptos Announces Pricing of Initial Public Offering of Common Stock 5/9/2013  More...
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 5/7/2013  More...
San Diego's Receptos, Ambit Biosciences, Get Ready for IPO Debuts 5/7/2013  More...
INSYS Therapeutics Announces Pricing of IPO 5/2/2013  More...
TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO 4/26/2013  More...
Omthera Pharmaceuticals, Inc. Prices Upsized IPO Below the Range at $8 4/11/2013  More...
Harvard Apparatus Postpones $19 Million IPO 4/10/2013  More...
Chimerix, Inc. Sets Terms for $85 Million IPO 4/2/2013  More...
Enanta Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option 3/27/2013  More...
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO 3/21/2013  More...
Zoetis (ZTS) Closes Initial Public Offering 2/7/2013  More...
KaloBios Pharmaceuticals, Inc. Completes Initial Public Offering 2/7/2013  More...
Stemline Therapeutics, Inc. (STML) Announces Closing of Initial Public Offering 2/1/2013  More...
Pfizer Inc. (PFE)'s Zoetis (ZTS) Hauls in $2.24 Billion in IPO 2/1/2013  More...
Stemline Therapeutics, Inc. (STML) Rises in Its Market Debut as First Biotech IPO of 2013 1/30/2013  More...
KaloBios Pharmaceuticals, Inc. on Path Toward $50 Million IPO 1/28/2013  More...
Vantiv Succeeds With IPO, Begins Rapid Acquisitions 12/28/2012  More...
Cancer Drug Spinoff of Australian Company, Audeo Oncology Inc. Preps $49 Million IPO 12/10/2012  More...
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock 10/26/2012  More...
BioIndustry Association Release: Latest French Biotech IPO Demonstrates the Potential of Citizens' Innovation Funds 10/25/2012  More...
ImmunoCellular Therapeutics, Ltd Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants 10/18/2012  More...
Anacor Pharmaceuticals, Inc. Prices $24 Million Public Offering of Common Stock 10/18/2012  More...
MannKind Corporation (MNKD) Prices Offering at 23 Pct Discount 10/18/2012  More...
Kythera Biopharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option 10/16/2012  More...
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs 10/12/2012  More...
Intercept Pharmaceuticals Announces Pricing of Initial Public Offering 10/11/2012  More...
Kythera Biopharmaceuticals Announces Pricing of Initial Public Offering 10/11/2012  More...
Isis Pharmaceuticals, Inc. (ISIS) Investment in Regulus Therapeutics, Inc. Valued at $28 Million at Completion of Regulus Initial Public Offering 10/11/2012  More...
Fosun Pharma's Hong Kong IPO Set to Raise $600 Million 10/5/2012  More...
Regulus Therapeutics, Inc. Announces Pricing of Initial Public Offering 10/4/2012  More...
Kythera Biopharmaceuticals Prices IPO 9/28/2012  More...
GlobeImmune, Inc. Offers IPO Details 9/6/2012  More...
China National Biotech Group Approved for $1.6 Billion Hong Kong IPO 9/6/2012  More...
The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs 8/21/2012  More...
Tigermed Completes $80 Million IPO on the ChiNext Exchange 8/20/2012  More...
Fluidigm Corporation Prices $52.2 Million Public Offering of Common Stock 8/16/2012  More...
Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen 8/15/2012  More...
Stemline Therapeutics, Inc. Postpones IPO 8/9/2012  More...
Hyperion Therapeutics Completes Initial Public Offering and Announces Exercise of Underwriters' Over-Allotment Option 8/1/2012  More...
Idenix Pharmaceuticals, Inc. (IDIX) Announces Proposed Public Offering of Common Stock 8/1/2012  More...
Hyperion Therapeutics Prices IPO at $10.00, Below the Range Expected 7/26/2012  More...
Durata Therapeutics, Inc. Closes Initial Public Offering 7/25/2012  More...
Zogenix, Inc. Prices Public Offering of Common Stock and Warrants to Purchase Common Stock 7/24/2012  More...
Durata Therapeutics, Inc. Prices $68 Million IPO 7/19/2012  More...
Tesaro, Inc. Announces Pricing of Initial Public Offering 6/28/2012  More...
Tesaro, Inc. Sets Terms for $81 Million US IPO 6/20/2012  More...
Cathay Industrial Biotech Withdraws $90 Million IPO 6/13/2012  More...
After Successful IPO, Verastem, Inc. (VSTM) Tries to Deliver on Promise 5/24/2012  More...
Cancer Genetics, Inc. Delays IPO to Avoid Faceoff with Facebook 5/21/2012  More...
China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO 5/18/2012  More...
Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct 5/11/2012  More...
Dynavax Technologies Corporation (DVAX) Sinks on Discounted Offering, CEO Exit 5/9/2012  More...
Supernus Pharmaceuticals Prices IPO at $5, Raising $50 Million 5/1/2012  More...
Fosun Pharma Given OK for Hong Kong IPO 4/12/2012  More...
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO 4/12/2012  More...
Shares of Merrimack Pharmaceuticals Inc. Stock Drops Post - IPO 3/30/2012  More...
Merrimack Pharmaceuticals Inc. Sets New IPO Terms, Aiming to Raise Less $ 3/28/2012  More...
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report 2/21/2012  More...
Beijing Leadman Biochemistry Completes ChiNext IPO 2/16/2012  More...
ChemoCentryx, Inc. (CCXI) Completes IPO 2/14/2012  More...
Chinese Drugmaker Guizhentang Pharmaceuticals' IPO Protested Over Bear Bile 2/13/2012  More...
Merrimack Pharmaceuticals Inc. Scraps IPO Plans 2/2/2012  More...
Verastem, Inc. Bucks the Trend, Raises $55 Million in IPO 1/27/2012  More...
ChemoCentryx, Inc. Sets $14-$16 Range for IPO 1/26/2012  More...
Xizang Haisco Pharma Completes $127 Million IPO 1/17/2012  More...
Verastem, Inc. 4.5 Million-Share IPO Seen Pricing at $9-$11 a Piece 1/17/2012  More...
Clovis Oncology (CLVS) Raises $130 Million in IPO 11/16/2011  More...
NewLink Genetics Raises $43.4 Million in IPO 11/11/2011  More...
China National Biotech Group's Hong Kong IPO to Raise Up to $2 Billion 11/9/2011  More...
Clovis Oncology Poised for IPO, Targets $13 to $15 Per Share 11/2/2011  More...
NewLink Genetics Estimates it Will Raise $53.4 Million From IPO 10/27/2011  More...
Sinocom Pharma Withdraws IPO Plans, Cites Market Conditions 10/14/2011  More...
Horizon Pharma, Inc. Announces Pricing of Its Initial Public Offering 7/28/2011  More...
Shijiazhuang Yiling Pharmaceutical Climbs in Post-IPO Trading 7/28/2011  More...
Tranzyme Pharma Announces Partial Exercise of Over-Allotment Option for Initial Public Offering 5/5/2011  More...
Sagent Pharmaceuticals, Inc. Announces Closing of 5.75M Share IPO 4/27/2011  More...





 

//-->